Cargando…
Fluid management: the pharmacoeconomic dimension
Cost is a key concern in fluid management. Relatively few data are available that address the comparative total costs of care between different fluid management regimens in particular clinical indications. Relevant costs of fluid-associated morbidity and mortality, including those incurred after int...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226174/ https://www.ncbi.nlm.nih.gov/pubmed/11255597 http://dx.doi.org/10.1186/cc969 |
_version_ | 1782217575337295872 |
---|---|
author | Vincent, Jean-Louis |
author_facet | Vincent, Jean-Louis |
author_sort | Vincent, Jean-Louis |
collection | PubMed |
description | Cost is a key concern in fluid management. Relatively few data are available that address the comparative total costs of care between different fluid management regimens in particular clinical indications. Relevant costs of fluid-associated morbidity and mortality, including those incurred after intensive care unit or hospital discharge, also need to be considered in evaluating the cost-benefit ratios of administered fluids. Rigorously designed pharmacoeconomic studies are needed to delineate the costs and benefits of various approaches to fluid management. |
format | Online Article Text |
id | pubmed-3226174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32261742011-11-30 Fluid management: the pharmacoeconomic dimension Vincent, Jean-Louis Crit Care Proceedings Cost is a key concern in fluid management. Relatively few data are available that address the comparative total costs of care between different fluid management regimens in particular clinical indications. Relevant costs of fluid-associated morbidity and mortality, including those incurred after intensive care unit or hospital discharge, also need to be considered in evaluating the cost-benefit ratios of administered fluids. Rigorously designed pharmacoeconomic studies are needed to delineate the costs and benefits of various approaches to fluid management. BioMed Central 2000 2000-10-13 /pmc/articles/PMC3226174/ /pubmed/11255597 http://dx.doi.org/10.1186/cc969 Text en Copyright ©2000 Current Science Ltd |
spellingShingle | Proceedings Vincent, Jean-Louis Fluid management: the pharmacoeconomic dimension |
title | Fluid management: the pharmacoeconomic dimension |
title_full | Fluid management: the pharmacoeconomic dimension |
title_fullStr | Fluid management: the pharmacoeconomic dimension |
title_full_unstemmed | Fluid management: the pharmacoeconomic dimension |
title_short | Fluid management: the pharmacoeconomic dimension |
title_sort | fluid management: the pharmacoeconomic dimension |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226174/ https://www.ncbi.nlm.nih.gov/pubmed/11255597 http://dx.doi.org/10.1186/cc969 |
work_keys_str_mv | AT vincentjeanlouis fluidmanagementthepharmacoeconomicdimension |